Nitric oxide regulates the expression of heme carrier protein-1 via hypoxia inducible factor-1α stabilization
Autoři:
Hiromi Kurokawa aff001; Hiromu Ito aff002; Masahiko Terasaki aff003; Daisuke Matano aff003; Atsushi Taninaka aff004; Hidemi Shigekawa aff004; Hirofumi Matsui aff001
Působiště autorů:
Faculty of Medicine, University of Tsukuba, Ibaraki, Japan
aff001; Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan
aff002; Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan
aff003; Faculty of Pure and Applied Sciences, University of Tsukuba, Ibaraki, Japan
aff004
Vyšlo v časopise:
PLoS ONE 14(9)
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pone.0222074
Souhrn
Photodynamic therapy (PDT) is a cancer therapy that capitalizes on cancer-specific porphyrin accumulation. We have investigated this phenomenon to propose the following three conclusions: 1) the mechanism underlying this phenomenon is closely related to both nitric oxide (NO) and heme carrier protein-1 (HCP-1), 2) NO inactivates ferrochelatase, and thus, the intracellular porphyrin levels in the cells are increased by the administration of an NO donor after 5-aminolevulinic acid treatment, 3) HCP-1 transports not only heme but also other porphyrins. Since NO stabilizes hypoxia-inducible factor (HIF)-1α, resulting in the upregulation of heme biosynthesis, HCP-1 expression can be increased by HIF-1α stabilization. In this study, we determined whether NO regulates HCP-1 expression by stabilizing HIF-1α expression. For this purpose, rat gastric cancer cell line RGK36 was treated with L-arginine or N6-(1-iminoethyl)-L-lysine (L-NIL). L-arginine treatment increased the intracellular NO concentration, and both HCP-1 and HIF-1α expression, while L-NIL treatment decreased them. Cytotoxicity of PDT was enhanced by L-arginine, following intracellular hemato-porphyrin dihydrochloride (HpD) accumulation. Both Cytotoxicity of PDT and HpD accumulation were decreased by L-NIL. The HCP-1 and HIF-1α expression, intracellular HpD accumulation and PDT cytotoxicity were decreased by 2-methoxyestradiol, which is a HIF-1α inhibitor. Moreover, these phenomena were not increased by a combination of both L-arginine and 2-Me. Thus, HCP-1 can be a downstream target of HIF-1α. These effects were also induced in the human gastric cancer cell line MKN45. Taken together, we conclude that HCP-1 expression is regulated by NO via HIF-1α stabilization.
Klíčová slova:
Biology and life sciences – Biochemistry – Physical sciences – Chemistry – Engineering and technology – Research and analysis methods – Proteins – Neuroscience – Medicine and health sciences – Chemical compounds – Pathology and laboratory medicine – Organic compounds – Organic chemistry – Oncology – Cancer treatment – Cancers and neoplasms – Neurochemistry – Neurochemicals – Equipment – Optical equipment – Gastrointestinal tumors – Gastric cancer – Electrophoretic techniques – Gel electrophoresis – Toxicology – Nitric oxide – Post-translational modification – Heme – Cytotoxicity – Porphyrins – Lasers
Zdroje
1. Rajesh S, Koshi E, Philip K, Mohan A. Antimicrobial photodynamic therapy: An overview. J Indian Soc Periodontol. 2011; 5: 323–327.
2. Malik R, Manocha A, Suresh DK. Photodynamic therapy—a strategic review. Indian J Dent Res. 2010; 21: 285–291. doi: 10.4103/0970-9290.66659 20657102
3. Luo D, Carter KA, Miranda D, Lovell JF. Chemophototherapy: An Emerging Treatment Option for Solid Tumors. Adv Sci (Weinh). 2017; 4: 1600106.
4. Lee JY and Lim JY. The Prospect of the Fourth Industrial Revolution and Home Healthcare in Super-Aged Society. Ann Geriatr Med Res. 2017; 21: 95–100.
5. Nishiwaki Y. The Advantages of Photodynamic Therapy for Gastric Cancer in This Era of an Increasing Elderly Population–From a Surgeon’s Point of View. Nippon Laser Igakkaishi, 2015; 36: 138–145.
6. Kwiatkowski S, Knap B, Przystupski D, Saczko J, Kędzierska E, Knap-Czop K, et al. Photodynamic therapy—mechanisms, photosensitizers and combinations. Biomed Pharmacother. 2018; 106: 1098–1107. doi: 10.1016/j.biopha.2018.07.049 30119176
7. Lee JB, Choi JY, Chun JS, Yun SJ, Lee SC, Oh J, et al. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin. Br J Dermatol. 2008; 159: 61–67. doi: 10.1111/j.1365-2133.2008.08611.x 18489589
8. Jedrych E, Chudy M, Dybko A, Brzozka Z. The microfluidic system for studies of carcinoma and normal cells interactions after photodynamic therapy (PDT) procedures. Biomicrofluidics. 2011; 5: 41101–411016. doi: 10.1063/1.3658842 22662052
9. Shayeghi M, Latunde-Dada GO, Oakhill JS, Laftah AH, Takeuchi K, Halliday N, et al. Identification of an intestinal heme transporter. Cell. 2005; 122: 789–801. doi: 10.1016/j.cell.2005.06.025 16143108
10. Andrews NC. Understanding heme transport. The New England journal of medicine. 2005; 353: 2508–2509. doi: 10.1056/NEJMcibr053987 16339100
11. Hiyama K, Matsui H, Tamura M, Shimokawa O, Hiyama M, Kaneko T, et al. Cancer cells uptake porphyrins via heme carrier protein 1. Journal of Porphyrins and Phthalocyanines. 2012; 16: 1–8.
12. Ito H, Matsui H, Tamura M, Majima HJ, Indo HP, Hyodo I. Mitochondrial reactive oxygen species accelerate the expression of heme carrier protein 1 and enhance photodynamic cancer therapy effect. Journal of clinical biochemistry and nutrition. 2014; 55: 67–71. doi: 10.3164/jcbn.14-27 25120282
13. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991; 43: 109–142. 1852778
14. Jadeski LC, Hum KO, Chakraborty C, Lala PK. Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. International journal of cancer. 2000; 86: 30–39. doi: 10.1002/(sici)1097-0215(20000401)86:1<30::aid-ijc5>3.0.co;2-i 10728591
15. Fukumura D, Yuan F, Endo M, Jain RK. Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions. The American journal of pathology. 1997; 150: 713–725. 9033284
16. Kiziltepe T, Hideshima T, Ishitsuka K, Ocio EM, Raje N, Catley L, et al. JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells. Blood. 2007; 110: 709–718. doi: 10.1182/blood-2006-10-052845 17384201
17. Shupik MA, Vanin AF, Alessenko AV. Interaction of the nitric oxide signaling system with the sphingomyelin cycle and peroxidation on transmission of toxic signal of tumor necrosis factor-alpha in ischemia-reperfusion. Biochemistry (Mosc). 2011; 76: 1197–1209. doi: 10.1134/S0006297911110010 22117546.
18. Yamamoto F, Ohgari Y, Yamaki N, Kitajima S, Shimokawa O, Matsui H, et al. The role of nitric oxide in delta-aminolevulinic acid (ALA)-induced photosensitivity of cancerous cells. Biochemical and biophysical research communications. 2007; 353: 541–546. doi: 10.1016/j.bbrc.2006.12.007 17196160
19. Matsui H, Udo J, Kaneko T, Shimokawa O, Hyodo I. Nitric Oxide induces Cancer Specific Fluorescence after Aminolevulic Acid Treatment. The Journal of Japan Society for Laser Surgery and Medicine. 2008; 29: 153–159.
20. Sandau KB, Fandrey J, Brune B. Accumulation of HIF-1alpha under the influence of nitric oxide. Blood. 2001; 97: 1009–1015. doi: 10.1182/blood.v97.4.1009 11159530
21. Lin C, McGough R, Aswad B, Block JA, Terek R. Hypoxia induces HIF-1alpha and VEGF expression in chondrosarcoma cells and chondrocytes. Journal of orthopaedic research: official publication of the Orthopaedic Research Society. 2004; 22: 1175–1181.
22. Jazwa A, Stoszko M, Tomczyk M, Bukowska-Strakova K, Pichon C, Jozkowicz A, et al. HIF-regulated HO-1 gene transfer improves the post-ischemic limb recovery and diminishes TLR-triggered immune responses—Effects modified by concomitant VEGF overexpression. Vascul Pharmacol. 2015; 71: 127–138. doi: 10.1016/j.vph.2015.02.011 25869523
23. Liu YL, Ang SO, Weigent DA, Prchal JT, Bloomer JR. Regulation of ferrochelatase gene expression by hypoxia. Life sciences. 2004; 75: 2035–2043. doi: 10.1016/j.lfs.2004.03.027 15312748
24. Shimokawa O, Matsui H, Nagano Y, Kaneko T, Shibahara T, Nakahara A, et al. Neoplastic transformation and induction of H+,K+ -adenosine triphosphatase by N-methyl-N'-nitro-N-nitrosoguanidine in the gastric epithelial RGM-1 cell line. In vitro cellular & developmental biology Animal. 2008; 44: 26–30.
25. Vannini F, Kashfi K, Nath N. The dual role of iNOS in cancer. Redox biology. 2015; 6: 334–343. doi: 10.1016/j.redox.2015.08.009 26335399
26. Moore WM, Webber RK, Jerome GM, Tjoeng FS, Misko TP, Currie MG. L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. Journal of medicinal chemistry. 1994; 37: 3886–3888. doi: 10.1021/jm00049a007 7525961
27. Brune B, Zhou J. Nitric oxide and superoxide: interference with hypoxic signaling. Cardiovascular research. 2007; 75: 275–282. doi: 10.1016/j.cardiores.2007.03.005 17412315
28. Park YK, Ahn DR, Oh M, Lee T, Yang EG, Son M, et al. Nitric oxide donor, (+/-)-S-nitroso-N-acetylpenicillamine, stabilizes transactive hypoxia-inducible factor-1alpha by inhibiting von Hippel-Lindau recruitment and asparagine hydroxylation. Molecular pharmacology. 2008; 74: 236–245. doi: 10.1124/mol.108.045278 18426857
29. Pribluda VS, Gubish ER Jr., Lavallee TM, Treston A, Swartz GM, Green SJ. 2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate. Cancer metastasis reviews. 2000; 19: 173–179. 11191057
30. Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS, et al. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer cell. 2003; 3: 363–375. 12726862
31. Liu YL, Ang SO, Weigent DA, Prchal JT, Bloomer JR. Regulation of ferrochelatase gene expression by hypoxia. Life Sci. 2004; 75: 2035–2043. doi: 10.1016/j.lfs.2004.03.027 15312748
Článok vyšiel v časopise
PLOS One
2019 Číslo 9
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Nejasný stín na plicích – kazuistika
- Masturbační chování žen v ČR − dotazníková studie
- Těžké menstruační krvácení může značit poruchu krevní srážlivosti. Jaký management vyšetření a léčby je v takovém případě vhodný?
- Fixní kombinace paracetamol/kodein nabízí synergické analgetické účinky
Najčítanejšie v tomto čísle
- Graviola (Annona muricata) attenuates behavioural alterations and testicular oxidative stress induced by streptozotocin in diabetic rats
- CH(II), a cerebroprotein hydrolysate, exhibits potential neuro-protective effect on Alzheimer’s disease
- Comparison between Aptima Assays (Hologic) and the Allplex STI Essential Assay (Seegene) for the diagnosis of Sexually transmitted infections
- Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania